HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Figures Only Full Text Full Text (PDF) Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Vuksan, V. Articles by Xu, Z. Search for Related Content PubMed PubMed Citation Articles by Vuksan, V. Articles by Xu, Z.

American Ginseng Improves Glycemia in Individuals with Normal Glucose Tolerance: Effect of Dose and Time Escalation

Department of Nutritional Sciences, Faculty of Medicine, University of Toronto and Clinical Nutrition and Risk Factor Modification Centre (V.V., M.P.S., J.L.S., V.Y.Y.K., E.W., U.B.-Z., T.F., A.L.J., L.A.L., R.G.J., Z.X.), St. Michael’s Hospital, Toronto, CANADA
Division of Metabolism and Endocrinology (V.V., L.A.L., R.G.J.), St. Michael’s Hospital, Toronto, CANADA

Address reprint requests to: Vladimir Vuksan, PhD, Clinical Nutrition and Risk Factor Modification Centre, St. Michael’s Hospital, #6 138-61 Queen Street East, Toronto, Ontario, M5C 2T2, CANADA. E-mail: v.vuksan{at}utoronto.ca

Objective: We studied the effect of escalating the dose and administration time of American ginseng (AG, Panax quinquefolius L.) in nondiabetic individuals to achieve further improvements in glucose tolerance seen previously when 3g of AG was taken 40 minutes before a 25g glucose challenge.

Methods: Ten nondiabetic individuals (6M:4F; mean ± STD: age = 41 ± 13 years, BMI = 24.8 ± 3.5 kg/m², FBG = 4.5 ± 0.1mmolL^-1) on 12 separate occasions, randomly received 0 (placebo), 3, 6 or 9g of ground AG root at 40, 80, or 120 minutes before a 25g oral glucose challenge. Capillary blood glucose was measured prior to ingestion of AG or placebo capsules and at 0, 15, 30, 45, 60 and 90 minutes from start of challenge.

Results: Compared with the placebo, 3, 6 and 9g of AG reduced (p<0.05) postprandial incremental glucose at 30, 45 and 60 minutes; also, 3 and 9g of AG did so at 90 minutes. At 60 minutes, 9g of AG reduced incremental postprandial glucose relative to 3g of AG (p<0.05). All AG doses reduced (p<0.05) area under the incremental glucose curve (3g, 26.6%; 6g, 29.3%; 9g, 38.5%). AG taken at different times did not have an additional influence on postprandial glycemia.

Conclusions: In nondiabetic individuals, 3, 6 or 9g of AG taken 40, 80 or 120 minutes before a glucose challenge similarly improved glucose tolerance.

Key words: American ginseng, Panax quinquefolius L., glucose tolerance, nondiabetic, dose, time of administration

This article has been cited by other articles:

				L. S. Lee, S. D. Wise, C. Chan, T. L. Parsons, C. Flexner, and P. S. Lietman Possible Differential Induction of Phase 2 Enzyme and Antioxidant Pathways by American Ginseng, Panax quinquefolius J. Clin. Pharmacol., May 1, 2008; 48(5): 599 - 609. [Abstract] [Full Text] [PDF]

				J. Z. Luo and L. Luo Ginseng on Hyperglycemia: Effects and Mechanisms Evid. Based Complement. Altern. Med., January 3, 2008; (2008) nem178v1. [Abstract] [Full Text] [PDF]

				J. Z. Luo and L. Luo American Ginseng Stimulates Insulin Production and Prevents Apoptosis through Regulation of Uncoupling Protein-2 in Cultured {beta} Cells Evid. Based Complement. Altern. Med., September 1, 2006; 3(3): 365 - 372. [Abstract] [Full Text] [PDF]

				J. L. Sievenpiper, M.-K. Sung, M. Di Buono, K. Seung-Lee, K. Y. Nam, J. T. Arnason, L. A. Leiter, and V. Vuksan Korean Red Ginseng Rootlets Decrease Acute Postprandial Glycemia: Results from Sequential Preparation- and Dose-Finding Studies. J. Am. Coll. Nutr., April 1, 2006; 25(2): 100 - 107. [Abstract] [Full Text] [PDF]

				C. Buettner, G. Y Yeh, R. S Phillips, M. A Mittleman, and T. J Kaptchuk Systematic Review of the Effects of Ginseng on Cardiovascular Risk Factors Ann. Pharmacother., January 1, 2006; 40(1): 83 - 95. [Abstract] [Full Text] [PDF]

				P. M. Stavro, M. Woo, T. F. Heim, L. A. Leiter, and V. Vuksan North American Ginseng Exerts a Neutral Effect on Blood Pressure in Individuals With Hypertension Hypertension, August 1, 2005; 46(2): 406 - 411. [Abstract] [Full Text] [PDF]

				D. V Aminot-Gilchrist and H. D. Anderson Insulin resistance--associated cardiovascular disease: potential benefits of conjugated linoleic acid Am. J. Clinical Nutrition, June 1, 2004; 79(6): 1159S - 1163S. [Abstract] [Full Text] [PDF]

				J. L. Sievenpiper, J. T. Arnason, L. A. Leiter, and V. Vuksan Decreasing, Null and Increasing Effects of Eight Popular Types of Ginseng on Acute Postprandial Glycemic Indices in Healthy Humans: The Role of Ginsenosides J. Am. Coll. Nutr., June 1, 2004; 23(3): 248 - 258. [Abstract] [Full Text] [PDF]

				J. L. Sievenpiper, J. T. Arnason, L. A. Leiter, and V. Vuksan Null and Opposing Effects of Asian Ginseng (Panax ginseng C.A. Meyer) on Acute Glycemia: Results of Two Acute Dose Escalation Studies J. Am. Coll. Nutr., December 1, 2003; 22(6): 524 - 532. [Abstract] [Full Text] [PDF]

				G. Y. Yeh, D. M. Eisenberg, T. J. Kaptchuk, and R. S. Phillips Systematic Review of Herbs and Dietary Supplements for Glycemic Control in Diabetes Diabetes Care, April 1, 2003; 26(4): 1277 - 1294. [Abstract] [Full Text] [PDF]

				Y. S. Chang, E.-K. Seo, C. Gyllenhaal, and K. I. Block Panax ginseng: Panax ginseng: A Role in Cancer Therapy? Integr Cancer Ther, March 1, 2003; 2(1): 13 - 33. [Abstract] [PDF]

				V. Vuksan, J. L. Sievenpiper, Z. Xu, E. Y. Y. Wong, A. L. Jenkins, U. Beljan-Zdravkovic, L. A. Leiter, R. G. Josse, and M. P. Stavro Konjac-Mannan and American Ginsing: Emerging Alternative Therapies for Type 2 Diabetes Mellitus J. Am. Coll. Nutr., October 1, 2001; 20(90005): 370S - 380. [Abstract] [Full Text]